AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

CYCLOPENTOLATE HYDROCHLORIDE

7 registrations across 5 African markets— 7 active

Markets with CYCLOPENTOLATE HYDROCHLORIDE

Recent registrations

Brand / ProductMarketHolderStatusExpires
CYCLO P
Eye Drops, Solution
🇰🇪KenyaABACUS PARENTERAL DRUGS LTDactiveNov 2030
PRINORELAX 30MG
CAPSULES
🇷🇼RwandaLIPTIS FOR PHARMACEUTICAL AND MEDICAL PRODUCTS (S.A.E)activeJul 2030
CYCLOLAT EYE DROPS
Eye Drops, Solution
🇰🇪KenyaGALAXY PHARMACEUTICAL LTDactiveSept 2027
Openna Eye Drops
Solution/Drops
🇳🇬NigeriaLin-Kabs Pharmaceutical LimitedactiveOct 2026
MINIMS CYCLOPENTOLATE* HYDROCHLORIDE 1%🇿🇦South AfricaSoflens (Pty) LtdactiveJan 1900
CYCLOPENTOLATE HYDROCHLORIDE
OPHTHALMIC DROPS
🇺🇬UgandaABACUS PARENTERAL DRUGS LIMITEDactive
CYCLOPENTOLATE HYDROCHLORIDE
OPHTHALMIC DROPS
🇺🇬UgandaABACUS PARENTERAL DRUGS LIMITEDactive

CYCLOPENTOLATE HYDROCHLORIDE in Africa — Regulatory Overview

CYCLOPENTOLATE HYDROCHLORIDE is registered across 5 African markets with 7 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Kenya, Uganda, Nigeria, Rwanda and 1 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 7 registrations, 7 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.